INDUCE-SEQ

Live / Registered — Registered (as of 11 Jun 2024)

What this means for you

Registered since 11 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
79362452
Registration number
7410775
Mark type
Stylized text
Filed
04 Aug 2022
Published for opposition
26 Mar 2024
Registered
11 Jun 2024
Attorney of record
Brendan J. Hughes

Goods and services

  • Class 001 — Chemicals: Biological preparations for use in agriculture, except fungicides, herbicides, insecticides, and parasiticides
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders; medical diagnostic reagents and assays for testing of body fluids; chemical reagents for medical purposes; pharmaceutical preparations for use in gene and cell therapies for the treatment of cancer, cardiovascular diseases and disorders, psychiatric diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders; pharmaceutical preparations for use in chemotherapies; diagnostic kits for medical purposes comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, cardiovascular diseases and disorders, psychiatric diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders; analytical test kits being medical diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, cardiovascular diseases and disorders, psychiatric diseases and disorders, neurological diseases and disorders, sleep conditions, diseases and disorders, central nervous system conditions, diseases and disorders, rare diseases and disorders, genetic diseases and disorders, oncological and hematological diseases and disorders, dermatological diseases and disorders, bone diseases and disorders, respiratory diseases and disorders, endocrinological diseases and disorders, circulatory diseases and disorders, gastroenterological diseases and disorders, hormonal diseases and disorders, diabetic diseases and disorders, digestive diseases and disorders, muscular diseases and disorders, immune system diseases and disorders, metabolic diseases and disorders, and ocular diseases and disorders
  • Class 009 — Scientific and electric apparatus: Downloadable computer software for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; downloadable mobile application software for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; apparatus and instruments for scientific or research purposes, namely, laboratory apparatus and instruments for genome sequencing, not for medical purposes
  • Class 010 — Medical apparatus: Blood test collection kits comprised of blood collection needles, blood collecting tubes, and blood collection bags for medical purposes; radiation therapy devices
  • Class 042 — Scientific and technological services: Analytical laboratory services, namely, scientific laboratory services; pharmaceutical research and development services; testing, inspection, research and development of pharmaceutical preparations for gene therapy; testing, inspection, research, and development of pharmaceutical preparations for cell therapies; genome scientific research services; development of new technology for others in the field of medical devices and medical diagnostic apparatuses; medical research services; medical research in the field of infectious disease monitoring and surveillance services; research and development services in the field of antibodies; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; medical research in the field of oncology; toxicity testing and analysis for foodstuffs for scientific research purposes; toxicity testing and analysis for household products for scientific research purposes; computer software development; providing temporary use of online non-downloadable software and software applications using artificial intelligence for medical analysis; software as a service (SaaS) featuring software for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; platform as a service (PaaS) featuring computer software platforms for the analysis of genomic data, gene editing data, cell culture data, therapeutic development data, and patient data; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; providing temporary use of on-line non-downloadable software and software applications for creating analytic and statistic models for data analysis
  • Class 044 — Medical, beauty and agricultural services: Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical diagnostic blood testing for identifying and determining the presence and stage of diseases; genome editing therapeutics

Owner

Prosecution history

  • 14 Dec 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 21 Nov 2024 — FINAL DISPOSITION NOTICE SENT TO IB
  • 21 Nov 2024 — FINAL DISPOSITION PROCESSED
  • 11 Sept 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 11 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 11 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
  • 26 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 26 Mar 2024 — PUBLISHED FOR OPPOSITION
  • 06 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 06 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 21 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 21 Feb 2024 — EXAMINER'S AMENDMENT ENTERED
  • 21 Feb 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 21 Feb 2024 — EXAMINERS AMENDMENT E-MAILED
  • 21 Feb 2024 — EXAMINERS AMENDMENT -WRITTEN

View this trademark record on Marksy